Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MetaMate is a digital health company focused on optimizing metabolic health through artificial intelligence and real-time data integration. The company's platform connects with continuous glucose monitors (CGMs) and other wearable devices to provide users with personalized, actionable insights into their glucose levels and metabolic responses. By leveraging AI-driven coaching, MetaMate assists individuals in managing weight, improving energy levels, and preventing chronic conditions such as type 2 diabetes. The service is designed to bridge the gap between raw health data and sustainable lifestyle changes for long-term wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meta Mate.